Epsilogen Ltd, a global leader in the development of novel immunoglobulin E antibodies to treat cancer, announced three new senior hires in what is a significant expansion of their management team.
Epsilogen Ltd, a global leader in the development of novel immunoglobulin E antibodies to treat cancer, announced three new senior hires in what is a significant expansion of their management team.